Risk stratification in Waldenström macroglobulinemia-Reference-Cited by-同舟云学术

Risk stratification in Waldenström macroglobulinemia

Published:2012-01 Issue:2 Volume:5 Page:187-199
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Morel Pierre,Merlini Giampaolo

Publisher

Informa UK Limited

Subject

Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1586/ehm.11.82

Reference79 articles.

1. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

2. SwerdlowSH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H. Lymphoplasmacytic lymphoma. In:WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, HarrisNLet al.(Eds). International Agency for Research on Cancer, Lyon, France (2008).

3. Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.

4. Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy;Hematology/Oncology Clinics of North America;2023-08

2. Rare presentation of Waldenström’s macroglobulinaemia requiring bilateral above-knee amputations: a case report;Journal of Medical Case Reports;2022-11-03

3. Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study;BMC Cancer;2020-07-03

4. High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia;Hematology/Oncology Clinics of North America;2018-10

5. Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan;International Journal of Hematology;2017-07-07